inform
influenza
vaccin
effect
ive
import
vaccin
strain
select
immun
polici
decis
testneg
design
tnd
casecontrol
studi
commonli
use
obtain
ive
estim
howev
definit
control
patient
may
influenc
ive
estim
conduct
tnd
studi
use
dutch
sentinel
practic
nivel
primari
care
databas
includ
data
patient
consult
gener
practition
gp
episod
acut
influenzalik
ill
ili
acut
respiratori
infect
ari
known
influenza
vaccin
statu
case
patient
test
posit
influenza
viru
control
group
test
neg
influenza
viru
influenza
neg
neg
influenza
viru
posit
respiratori
syncyti
viru
rhinoviru
enteroviru
noninfluenza
viru
posit
neg
four
virus
panneg
estim
ive
epidem
season
pool
ive
influenza
vaccin
partialful
match
mismatch
season
individu
season
use
gener
linear
mixedeffect
multipl
logist
regress
model
overal
ive
adjust
age
gp
iliari
diagnosi
chronic
diseas
respiratori
allergi
ci
ci
ci
influenza
neg
noninfluenza
viru
posit
panneg
control
respect
main
subgroup
analys
ive
estim
highest
use
noninfluenza
viru
posit
control
like
due
limit
inclus
control
without
laboratoryconfirm
viru
caus
respiratori
diseas
effect
way
prevent
influenza
viru
infect
sever
ill
vaccin
howev
composit
influenza
vaccin
reconsid
annual
eventu
updat
due
amino
acid
substitut
caus
antigen
drift
hemagglutinin
neuraminidas
viru
surfac
protein
occur
continu
time
escap
neutral
immun
respons
despit
yearli
updat
abil
vaccin
prevent
influenza
viru
infect
gener
popul
influenza
season
vaccin
effect
vari
year
henc
inform
import
immun
polici
decis
maker
eg
decid
type
vaccin
use
ie
inactiv
live
attenu
viru
without
adjuv
immun
eg
health
care
worker
children
elderli
howev
possibl
determin
influenza
season
therefor
retrospect
studi
use
observ
data
perform
estim
annual
testneg
design
tnd
casecontrol
studi
commonli
use
studi
design
estim
influenza
ive
studi
design
patient
seek
medic
care
influenzalik
ill
ili
test
influenza
viru
infect
ive
http
determin
compar
preval
influenza
vaccin
ili
patient
test
posit
influenza
case
test
neg
influenza
control
case
control
select
patient
seek
medic
care
ili
studi
design
assum
minim
confound
health
careseek
behavior
function
statu
compar
type
observ
studi
moreov
laboratori
test
use
defin
influenza
outcom
compar
studi
design
use
nonspecif
influenza
outcom
eg
ili
symptom
reduc
misclassif
bia
sever
studi
shown
definit
control
group
tnd
studi
may
influenc
estim
ive
three
type
control
group
use
tnd
studi
ili
patient
test
neg
influenza
viru
infect
influenza
neg
ili
patient
test
neg
influenza
viru
posit
anoth
respiratori
viru
noninfluenza
viru
posit
ili
patient
test
neg
influenza
viru
respiratori
virus
panneg
although
influenza
neg
control
commonli
use
sever
studi
noninfluenza
viru
posit
control
use
argu
anoth
respiratori
viru
influenza
viru
could
detect
control
group
presenc
misclassif
highli
unlik
confirm
infecti
caus
ili
case
control
base
fact
laboratori
test
influenza
viru
use
case
control
hand
investig
argu
presenc
noninfluenza
respiratori
viru
infect
could
partli
explain
associ
influenza
vaccin
increas
risk
anoth
respiratori
viru
infect
due
temporari
nonspecif
immun
respons
consequ
definit
second
control
group
could
lead
select
bia
therebi
overestim
ive
sinc
risk
ili
symptom
caus
anoth
pathogen
would
higher
vaccin
patient
unvaccin
patient
result
higher
proport
vaccin
individu
control
group
consequ
sever
studi
use
panneg
control
aim
present
studi
estim
ive
ten
influenza
epidem
season
netherland
use
three
commonli
appli
definit
tnd
control
group
evalu
differ
among
ive
estim
use
data
sentinel
practic
nivel
primari
care
databas
sampl
patient
ili
anoth
acut
respiratori
infect
ari
laboratori
diagnost
start
sinc
particip
gener
practition
gp
ask
take
nose
throat
swab
two
ili
patient
week
sinc
addit
instruct
sampl
prefer
one
patient
less
year
age
ili
patient
encount
gp
ask
swab
patient
anoth
ari
instead
offici
standard
definit
ili
use
gp
offic
diagnos
patient
ili
name
acut
onset
symptom
full
develop
typic
symptom
day
includ
rectal
temperatur
least
least
one
respiratori
system
symptom
ie
cough
nasal
catarrh
sore
throat
frontal
headach
retrostern
pain
myalgia
ari
defin
acut
respiratori
ill
ili
acut
sinus
pneumonia
least
one
follow
symptom
cough
rhinorrhea
sore
throat
ili
ari
patient
includ
studi
maxim
power
patient
inform
regist
sampl
form
eg
person
inform
gender
age
date
symptom
onset
swab
use
antivir
medic
underli
medic
condit
surveil
studi
regist
person
data
protect
act
regist
dutch
person
data
protect
commiss
ethic
approv
need
sinc
anonym
data
use
current
studi
collect
sampl
swab
subject
sent
nation
institut
public
health
environ
rivm
laboratori
test
number
pathogen
pathogen
identifi
use
viru
isol
andor
revers
transcript
polymeras
chain
reaction
rtpcr
rtpcr
chang
time
convent
blockbas
realtim
format
necessari
adjust
primer
probe
design
laboratori
test
respiratori
virus
influenza
viru
respiratori
syncyti
virus
influenza
season
patient
select
swab
week
week
follow
year
patient
exclud
vaccin
statu
unknown
time
symptom
onset
swab
seven
day
patient
receiv
antivir
medic
within
two
week
prior
gp
visit
date
swab
first
decemb
season
make
sure
vaccin
given
day
symptom
onset
data
miss
variabl
ie
gender
age
iliari
diagnosi
underli
chronic
diseas
respiratori
allergi
patient
swab
season
exclud
sinc
atyp
pandem
influenza
season
elig
swab
patient
test
posit
influenza
viru
b
regard
case
control
defin
patient
test
neg
influenza
viru
influenza
neg
neg
influenza
viru
posit
rsv
rv
ev
noninfluenza
viru
posit
neg
four
respiratori
virus
panneg
includ
rsv
rv
ev
sinc
virus
test
throughout
whole
studi
period
chisquar
test
use
test
signific
differ
proport
categor
covari
ttest
differ
mean
age
case
control
group
pvalu
consid
statist
signific
ive
calcul
ive
influenza
vaccin
statu
exposur
unadjust
adjust
ive
potenti
confound
estim
ie
age
iliari
diagnosi
respiratori
allergi
underli
chronic
diseas
eg
asthma
chronic
obstruct
pulmonari
diseas
diabet
mellitu
cardiovascular
diseas
influenza
season
level
vaccin
match
variabl
associ
outcom
chang
retain
final
gener
linear
mixedeffect
model
glmm
multipl
logist
regress
model
confid
interv
ci
contain
zero
neg
valu
ive
consid
signific
glmm
influenza
season
model
random
effect
use
estim
ive
season
season
categor
level
vaccin
match
vaccin
match
statu
categor
partial
match
mismatch
base
circul
influenza
virus
season
influenza
vaccin
use
inform
extract
data
publish
dutch
nation
influenza
center
multipl
logist
regress
model
use
assess
ive
individu
season
statist
analys
conduct
use
sa
softwar
version
r
version
perform
sever
sensit
analysi
estim
influenza
viru
neg
patient
test
posit
least
one
neg
virus
consid
noninfluenza
viru
posit
panneg
control
respect
sensit
analysi
conduct
sinc
definit
control
group
similar
previous
conduct
studi
gp
dutch
sentinel
practic
network
swab
total
patient
fulfil
inand
exclus
criteria
studi
tabl
major
subject
exclud
swab
outsid
influenza
season
subject
exclud
sinc
inform
eg
age
clinic
diagnosi
influenza
vaccin
miss
time
symptom
onset
swab
seven
day
receiv
antivir
medic
within
two
week
prior
tabl
characterist
case
three
differ
control
group
influenza
neg
control
group
noninfluenza
viru
posit
control
group
panneg
control
group
gp
visit
includ
subject
total
patient
test
posit
influenza
viru
case
test
neg
influenza
viru
among
patient
test
neg
influenza
viru
test
posit
rsv
rv
ev
noninfluenza
viru
posit
test
neg
virus
panneg
statist
signific
differ
age
gp
iliari
diagnosi
presenc
chronic
diseas
influenza
vaccin
statu
found
case
differ
control
group
compar
control
group
case
younger
like
diagnos
ili
lower
proport
chronic
diseas
influenza
vaccin
addit
statist
signific
differ
age
diagnosi
compar
noninfluenza
viru
posit
panneg
control
panneg
control
older
like
diagnos
ili
compar
noninfluenza
viru
posit
control
see
tabl
compar
unadjust
ive
estim
ive
estim
adjust
possibl
confound
factor
age
iliari
diagnosi
chronic
diseas
respiratori
allergi
influenza
season
chang
therefor
follow
paragraph
ive
estim
adjust
confound
factor
shown
influenza
season
paramet
includ
estim
seasonspecif
ive
adjust
ive
estim
season
ci
use
influenza
neg
control
fig
use
noninfluenza
viru
posit
control
ive
increas
wherea
ive
decreas
ci
use
panneg
control
tabl
pool
adjust
ive
estim
partial
match
season
ci
ci
ci
influenza
neg
noninfluenza
viru
posit
panneg
control
respect
fig
pool
adjust
ive
estim
mismatch
season
ci
ci
ci
control
group
respect
adjust
ive
estim
differ
individu
influenza
season
vari
neg
ive
estim
fig
result
sensit
analysi
summar
tabl
gener
point
ive
estim
vari
differ
definit
control
patient
gener
season
highest
use
noninfluenza
viru
posit
control
follow
respect
influenza
neg
control
panneg
control
consist
studi
similar
differ
ive
estim
found
studi
perform
portug
ive
estim
mismatch
influenza
season
among
ili
patient
test
rsv
piv
hmpv
rv
adv
defin
control
group
patient
hand
american
studi
estim
ive
six
influenza
season
among
children
adult
age
year
older
found
minor
differ
ive
estim
use
differ
control
group
base
detect
virus
portug
studi
enteroviru
howev
studi
perform
australia
estim
ive
children
match
influenza
season
season
use
influenza
neg
noninfluenza
posit
control
found
highest
ive
estim
use
noninfluenza
posit
control
ive
estim
partial
match
season
use
noninfluenza
posit
control
studi
higher
ive
estim
dutch
random
control
trial
rct
conduct
patient
age
year
older
ci
match
season
moreov
ive
estim
mismatch
season
studi
also
higher
ive
estim
found
cochran
review
rct
healthi
subject
age
year
use
noninfluenza
posit
control
ci
variat
ive
estim
use
differ
control
group
explain
select
bia
misclassif
bia
order
reduc
select
bia
sever
studi
suggest
includ
noninfluenza
ili
patient
test
neg
respiratori
virus
control
panneg
control
suggest
base
assumpt
influenza
vaccin
may
increas
risk
noninfluenza
respiratori
viru
infect
temporari
nonspecif
immun
viral
interfer
result
higher
proport
vaccin
individu
control
group
studi
found
indic
influenza
vaccin
might
increas
risk
noninfluenza
respiratori
viru
infect
vaccin
patient
observ
differ
vaccin
coverag
noninfluenza
posit
control
panneg
control
coverag
group
p
other
indic
temporari
nonspecif
immun
present
short
last
respons
around
two
week
therefor
unlik
respons
influenc
risk
noninfluenza
respiratori
virus
throughout
full
studi
period
sinc
includ
swab
patient
receiv
vaccin
least
day
symptom
onset
although
explan
true
assum
individu
suscept
influenza
viru
infect
begin
studi
period
time
infect
taken
account
especi
question
popul
patient
repres
panneg
control
sinc
iliari
patient
test
neg
evalu
respiratori
virus
ie
iliari
patient
without
infect
one
test
pathogen
panneg
patient
might
suscept
health
careseek
behavior
therefor
includ
higher
proport
iliari
caus
infect
sinc
patient
control
group
older
preval
chronic
diseas
higher
compar
case
control
group
also
delay
swab
might
play
role
sinc
time
symptom
onset
swab
influenc
sensit
laboratori
test
time
swab
symptom
onset
greater
sensit
influenza
b
virus
rtpcr
detect
decreas
eg
day
till
day
delay
studi
panneg
patient
swab
day
symptom
onset
compar
influenza
neg
noninfluenza
viru
posit
control
sensit
laboratori
test
also
import
assumpt
includ
patient
test
neg
influenza
viru
posit
anoth
respiratori
viru
control
group
noninfluenza
posit
control
inclus
control
group
base
assumpt
laboratori
test
adequ
case
control
therebi
elimin
falseneg
control
misclassif
bia
howev
current
studi
differ
laboratori
techniqu
use
detect
infect
one
test
pathogen
rtpcr
use
throughout
whole
studi
period
detect
influenza
viru
rsv
rv
ev
infect
howev
due
innov
techniqu
studi
period
sensit
assay
increas
littl
might
reduc
misclassif
later
season
furthermor
season
viru
isol
use
detect
rv
ev
also
method
use
detect
piv
viru
infect
viru
isol
lower
sensit
rtpcr
due
sensit
gap
misclassif
patient
still
rule
absolut
sensit
analysi
exclud
season
overal
estim
show
higher
ive
estim
compar
primari
analysi
especi
use
influenza
neg
panneg
control
signific
differ
ive
estim
could
observ
use
differ
control
group
confid
interv
overlap
primari
analysi
includ
pandem
season
overal
estim
almost
ident
estim
primari
analysi
howev
restrict
patient
swab
within
day
diseas
onset
ive
estim
decreas
especi
use
noninfluenza
posit
control
also
sensit
analysi
use
sever
extra
respiratori
pathogen
defin
control
group
show
slightli
differ
ive
estim
compar
primari
analysi
includ
three
respiratori
virus
definit
control
group
howev
gener
trend
increas
decreas
ive
could
observ
compar
ive
estim
primari
sensit
analys
may
explain
rel
infrequ
occurr
infect
primari
care
abl
analyz
ive
estim
sever
season
among
dutch
gener
practic
popul
use
tnd
studi
differ
control
group
howev
studi
sever
limit
firstli
certain
level
misclassif
might
present
noninfluenza
viru
posit
control
panneg
control
due
differ
sensit
laboratori
test
use
detect
pathogen
especi
detect
rtpcr
detect
viru
isol
secondli
due
limit
number
elig
patient
patient
diagnos
gp
ili
ari
includ
studi
maxim
power
howev
may
differ
health
careseek
behavior
two
patient
group
could
result
misclassif
bia
moreov
patient
sentinel
practic
nivel
primari
care
databas
network
systemat
sampl
iliari
patient
popul
sinc
person
iliari
visit
gp
visit
gp
gp
strict
instruct
patient
sampl
eg
first
patient
week
addit
subject
hospit
influenza
viru
infect
first
aid
cover
nivel
primari
care
databas
sinc
subject
swab
hospit
despit
includ
ili
ari
patient
number
elig
patient
limit
result
wide
confid
interv
statist
signific
ive
estim
final
inform
vaccin
statu
per
individu
patient
exactli
collect
might
result
misclassif
bia
howev
sinc
inhabit
netherland
regist
one
gp
offic
assum
gp
vaccin
patient
gp
take
inform
registri
data
patient
studi
show
differ
ive
estim
use
three
differ
control
group
line
studi
panneg
control
seem
less
valid
high
proport
patient
group
like
consult
gp
noninfecti
caus
ili
ari
symptom
use
noninfluenza
posit
control
ive
estim
consist
previou
effect
studi
clinic
trial
data
like
due
limit
control
without
infecti
caus
respiratori
diseas
control
laboratori
confirm
infect
explain
ili
ari
symptom
nevertheless
use
noninfluenza
posit
control
higher
ive
estim
found
primari
analysi
mismatch
season
compar
match
season
expect
base
sensit
analysi
seem
caus
mismatch
season
futur
studi
use
tnd
design
take
account
potenti
impact
defin
control
group
well
vaccin
match
statu
studi
studi
design
need
confirm
find
give
clear
statement
differ
observ
control
group
futur
research
studi
design
includ
patient
abl
detect
statist
signific
ive
estim
especi
sinc
adjust
confound
need
possibl
done
expand
gp
network
increas
number
patient
gp
swab
pool
data
sever
countri
addit
recommend
futur
studi
use
feasibl
standard
equalsensit
test
pathogen
detect
throughout
whole
studi
period
minim
misclassif
bia
although
innov
diagnost
test
increas
sensit
ignor
